Pritelivir
Pritelivir (BAY 57-1293) is an antiviral helicase-primase complex inhibitor.[1]
Names | |
---|---|
IUPAC name
N-Methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-(4-pyridin-2-yl-phenyl)acetamide | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C18H18N4O3S2 | |
Molar mass | 402.49 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
References
- Wozniak, M. A; Frost, A. L; Itzhaki, R. F (2013). "The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1". Antiviral Research. 99 (3): 401–4. doi:10.1016/j.antiviral.2013.07.003. PMID 23867133.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.